CRISPR-Cas system as a promising player against bacterial infection and antibiotic resistance
Drug Resistance Updates · 2023-05 · 68 · 100948
DOI: 10.1016/j.drup.2023.100948 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2023-05. Verfasst von Mohammad Abavisani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Student research committee, Mashhad University of Medical Sciences, Mashhad, the Islamic Republic of Iran; Department of Microbiology and Virology, F…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Bacterial Infections. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 222 Literaturangaben.
Abstract (Originalsprache)
The phenomenon of antibiotic resistance (AR) and its increasing global trends and destructive waves concerns patients and the healthcare system. In order to combat AR, it is necessary to explore new strategies when the current antibiotics fail to be effective. Thus, knowing the resistance mechanisms and appropriate diagnosis of bacterial infections may help enhance the sensitivity and specificity of novel strategies. On the other hand, resistance to antimicrobial compounds can spread from resistant populations to susceptible ones. Antimicrobial resistance genes (ARGs) significantly disseminate AR via horizontal and vertical gene transfer. The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas system is a member of the bacterial immune system with the ability to remove the ARGs; therefore, it can be introduced as an effective and innovative strategy in the battle against AR. Here, we reviewed CRISPR-based bacterial diagnosis technologies. Moreover, the strategies to battle AR based on targeting bacterial chromosomes and resistance plasmids using the CRISPR-Cas system have been explained. Besides, we have presented the limitations of CRISPR delivery and potential solutions to help improve the future development of CRISPR-based platforms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Student research committee, Mashhad University of Medical Sciences, Mashhad, the Islamic Republic of Iran; Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, t…
- Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, the Islamic Republic of Iran.
- Student research committee, Mashhad University of Medical Sciences, Mashhad, the Islamic Republic of Iran.
- Non communicable Diseases Research Center, Bam University of Medical sciences, Bam, the Islamic Republic of Iran.
- Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India; Center for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College, Saveetha…
- Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, the Islamic Republic of Iran; Applied Biomedical Research Center, Mashhad University of Medical Scienc…
Zitieren
APA
Abavisani, M., Khayami, R., Hoseinzadeh, M., Kodori, M., Kesharwani, P., & Sahebkar, A. (2023). CRISPR-Cas system as a promising player against bacterial infection and antibiotic resistance. Drug Resistance Updates, 68, 100948. https://doi.org/10.1016/j.drup.2023.100948
Vancouver
Abavisani M, Khayami R, Hoseinzadeh M, Kodori M, Kesharwani P, Sahebkar A. CRISPR-Cas system as a promising player against bacterial infection and antibiotic resistance. Drug Resistance Updates. 2023;68:100948. doi:10.1016/j.drup.2023.100948
BibTeX
@article{Abavisani2023,
author = {Abavisani, Mohammad and Khayami, Reza and Hoseinzadeh, Melika and Kodori, Mansoor and Kesharwani, Prashant and Sahebkar, Amirhossein},
title = {CRISPR-Cas system as a promising player against bacterial infection and antibiotic resistance},
journal = {Drug Resistance Updates},
year = {2023},
volume = {68},
pages = {100948},
doi = {10.1016/j.drup.2023.100948}
}
EUVIMED